GOLDMAN SACHS GROUP INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 47 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,912,000
-0.1%
5,000,0000.0%0.00%0.0%
Q2 2021$4,916,000
-47.4%
5,000,000
-48.4%
0.00%
-50.0%
Q1 2021$9,344,000
+47.2%
9,693,000
+44.8%
0.00%0.0%
Q4 2020$6,347,000
-37.4%
6,693,000
-39.2%
0.00%
-33.3%
Q3 2020$10,132,000
-23.2%
11,000,000
-26.7%
0.00%
-25.0%
Q2 2020$13,201,000
-12.3%
15,000,000
-20.0%
0.00%
-20.0%
Q1 2020$15,057,000
+115.3%
18,752,000
+142.7%
0.01%
+150.0%
Q4 2019$6,992,0007,725,0000.00%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders